Application of dental pulp stem cell exosome in preparation of medicine for treating and preventing osteoarthritis
By preparing dental pulp stem cell exosomes and applying them to drugs, the shortcomings of existing osteoarthritis treatments have been addressed, achieving the protection and repair of chondrocytes and demonstrating the important significance of dental pulp stem cell exosomes in the treatment of osteoarthritis.
Patent Information
- Application Number
- CN202511910585.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2025-12-17
- Publication Date
- 2026-02-17
AI Technical Summary
Existing treatments for osteoarthritis cannot fundamentally repair cartilage, regulate the intra-articular environment, or stop disease progression. Furthermore, direct stem cell transplantation presents challenges such as complex procedures, poor safety profiles, and immune rejection.
By utilizing dental pulp stem cell exosomes, a primary articular chondrocyte system was constructed in vitro to prepare dental pulp stem cell exosomes and apply them to drugs. The bioactive substances secreted by these exosomes, such as cytokines, growth factors, and miRNAs, can inhibit endoplasmic reticulum stress-induced senescence of chondrocytes and protect and repair cartilage.
Dental pulp stem cell exosomes effectively inhibited IL-1β-promoted endoplasmic reticulum stress-induced senescence in chondrocytes, demonstrating strong cartilage protection and repair capabilities. They have the advantages of simple operation, high safety, and avoidance of immune rejection, and can improve the pathological process of osteoarthritis.